Table 3. Mean monthly costs according to phase of treatment in 2013 $US.

	Intensive phase (0–6 months) (n = 84)			Continuation phase (7–24 months) (n = 50)
Duration on treatment	mean ± SD	median [IQR]	Proportion of minimum monthly wage %	mean ± SD	median [IQR]	Proportion of minimum monthly wage %
Direct costs
Private health care	1.7 ± 7.3	0	1.1	1.4 ± 8.1	0	0.8
Transport	2.1 ± 7.4	0	0.9	10.5 ± 35	0 [0–3.1]	5.8
Miscellaneous	9.2 ± 31.7	0 [0–5.7]	5.1	2.9 ± 9.9	0	1.6
Nutritional diet supplements	16.3 ± 37	4.2 [0–14.3]	9.0	44 ± 46	35 [10–62]	24.1
Subtotal (direct)	29.2		16.1	58.5		32.3
Indirect costs
Productivity loss: seeking care	7.7 ± 14.2	0 [0–10.3]	4.2	4.1 ± 6.5	1.3 [0.3–4.9]	2.3
Productivity loss: hospitalisation	173.2 ± 190	115.6 [10–227]	95.4	90 ± 229	0 [0–8.3]	49.5
Carer costs	12.6 ± 40.8	1.8 [0–4.6]	6.9	32.9 ± 102	0 [0–5.1]	18.1
Subtotal (indirect)	193.5		106.6	127.0		70.0
Coping costs
Interest on loans	0.6 ± 4	0	0.3	2.6 ± 9	0 [0–2.6]	1.5
Mean monthly costs, US$	223.3		123.0	188.1		103.7
Total costs, $US*	4725.6

^*Total costs for one MDR-TB treatment episode.

SD = standard deviation; IQR = interquartile range.